期刊文献+

雷公藤内酯醇及其衍生物的神经保护作用及机制 被引量:13

Neuroprotective effects of triptolide and its derivatives and their mechanisms of action
下载PDF
导出
摘要 雷公藤是我国的传统中药,雷公藤内酯醇是雷公藤提取物中具有抗炎和免疫调节活性功能的主要成分。近年来,大量证据表明,雷公藤内酯醇及其衍生物(雷公藤氯内酯醇和5-羟雷公藤内酯醇)对帕金森病、阿尔茨海默病、多发性硬化等神经变性疾病具有明确的神经保护作用。现代药理学研究表明,雷公藤内酯醇及其衍生物的神经保护作用机制与其抑制小胶质细胞活化及炎性反应因子释放、抑制氧化应激、拮抗兴奋性氨基酸毒性、抑制钙超载以及促进神经营养因子的合成有关。进一步的研究表明,雷公藤内酯醇及其衍生物主要通过影响MAPKs和NF-κB信号转导通路发挥神经保护作用。 Tripterygium wilfordii hook.f.is a kind of herb in traditional Chinese medicine(TCM).Triptolide(T10) is the major active component of tripterygium extracts which possesses potent anti-inflammatory and immunosuppressive properties.Recently,more and more evidences have indicated that T10 and its analogues(tripchlorolide and 5-hydroxytriptolide) had neuroprotective effects on various neurodegenerative diseases,such as Parkinson's disease(PD),Alzheimer's disease(AD) and multiple sclerosis(MS).Their neuroprotective mechanisms were involved in the inhibiting of microglial activation and release of pro-inflammatory cytokines,attenuating oxidative stress,suppression of excitotoxicity and Ca2+ overloading,and increasing the production of neurotrophic factors.The underlying molecular mechanisms were found to be associated with mitogen-activated protein kinases(MAPKs) and NF-κB signal pathways.
出处 《首都医科大学学报》 CAS 北大核心 2011年第6期859-864,共6页 Journal of Capital Medical University
基金 国家重点基础研究发展计划(973项目)(2011CB504100) 国家自然科学基金项目(81030062)~~
关键词 雷公藤内酯醇及其衍生物 神经保护 神经变性疾病 triptolide and its derivatives neuroprotective effect neurodegenerative diseases
  • 相关文献

参考文献5

二级参考文献29

  • 1吕诚,胡小令,张宪郁,温蔚.雷公藤多甙对大鼠海马内注射β-淀粉样蛋白后小胶质细胞反应的影响[J].解剖学杂志,2005,28(2):225-226. 被引量:7
  • 2杨光忠,陈玉.雷公藤氯内酯醇研究进展[J].中药材,2006,29(2):200-203. 被引量:9
  • 3Streit W J. Microglia and Alzheimer's disease pathogenesis [J]. J Neurosci Res, 2004;77(1) : 1 -8.
  • 4Etminan M, Gill S, Samii A. Effect of non-steroidal anti inflammatory drugs on risk of Alzheimer's disease: systematic review and meta-analysis of observational studies [J]. Br Med J, 2003, 327(7407): 128.
  • 5in 't Veld B A, Launer L J, Breteler M M, et al. Pharmacologic agents associated with a preventive effect on Alzheimer's disease: a review of the epidemiologic evidence[J]. Epidemiol Rev, 2002, 24(2) :248 -268.
  • 6Choi Y, Kim H S Shin K Y, et al. Minocycline attenuates neuronal cell death and improves cognitive impairment in Alzheimer's disease models [J]. Neuropsychopharmacology, 2007, 32 (11)2393-2404.
  • 7Fan R, Xu F, Previti M L, et al. Minocycline reduces microglial activation and improves behavioral deficits in a transgenic model of cerebral microvascular amyloid [J]. J Neurosci, 2007,27 (12) : 3057-3063.
  • 8Ramirez B G, Blazquez C, Gomez del Pulgar T, et al. Prevention of Alzheimer's disease pathology by cannabinoids: neuroprotection mediated by blockade of microglial activation [J]. J Neurosci, 2005,25(8) : 1904-1913.
  • 9El K J, Hichman S E, Thomas C A, et al. Scavenger receptormediated adhesion of microglia to β-amyloid fibrils [J]. Nature, 1996,382 (6593):716-719.
  • 10[1]Olson L, Backman L, Ebendal T, Eriksdotter-Jonhagen M,Hoffer B, Humpel C, Freedman R, Giacobini M, Meyerson B,Nordberg A. Role of growth factors in degeneration and regeneration in the central nervous system; clinical experiences with NGF in Parkinson's and Alzheimer's disease. J Neurol 1994;242:12-15.

共引文献71

同被引文献263

引证文献13

二级引证文献110

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部